<DOC>
	<DOCNO>NCT02030600</DOCNO>
	<brief_summary>This trial conduct United States America ( USA ) . The aim trial compare safety efficacy insulin degludec ( IDeg ) insulin glargine ( IGlar ) without OADs ( oral anti-diabetic drug ) exclude SUs ( sulfonylurea ) /glinides subject type 2 diabetes .</brief_summary>
	<brief_title>A Trial Comparing Safety Efficacy Insulin Degludec Insulin Glargine , With Without OADs Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Male female , age least 18 year time signing informed consent Subjects fulfil least one criterion : ) Experienced least one severe hypoglycaemic episode within last year ( accord ADA ( American Diabetes Association ) definition , April 2013 ) , b ) Moderate chronic renal failure , define glomerular filtration rate 30 59 mL/min/1.73 m^2 per CKDEpi ( Chronic Kidney Disease Epidemiology Collaboration ) central laboratory analysis , c ) Hypoglycaemic symptom unawareness , ) Exposed insulin 5 year , e ) Recent episode hypoglycaemia ( define symptom hypoglycaemia and/or episode low glucose measurement ( equal 70 mg/dL [ equal 3.9 mmol/L ] ) ) within last 12 week prior Visit 1 ( screen ) Type 2 diabetes mellitus ( diagnose clinically ) least 26 week prior Visit 1 Current treatment basal insulin ( OD BID ) Â± combination OADs ( metformin , DPP4 inhibitor , alphaglucosidase inhibitor , thiazolidinediones , SGLT2inhibitor ) 26 week longer prior Visit 1 For subject BID total daily dose 75 unit HbA1c ( glycosylated haemoglobin ) equal 9.5 % central laboratory analysis BMI ( body mass index ) equal 45 kg/m^2 Treatment bolus insulin separately contain insulin mix product within last 26 week prior Visit 1 Use antidiabetic agent ( ) state inclusion criterion within last 26 week prior Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>